BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

Advanced Search

7 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Cholecystokinin antagonists. Synthesis and biological evaluation of 3-substituted benzolactams.EBI
Merck Sharp & Dohme Research Laboratories
Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin.EBI
Centre De Pharmacologie-Endocrinologie (Montpellier, France)
Cholecystokinin antagonists. Synthesis and biological evaluation of 3-substituted 1,4-benzodiazepin-2-amines.EBI
Merck Sharp & Dohme Research Laboratories
Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.EBI
TBA
Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubility.EBI
TBA
Molecular Mechanism of Action of Triazolobenzodiazepinone Agonists of the Type 1 Cholecystokinin Receptor. Possible Cooperativity across the Receptor Homodimeric Complex.EBI
Mayo Clinic
Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists.EBI
TBA